SalWe is a platform for cooperation between companies, universities, research institutions and healthcare professionals. Its activities foster the international business operations of the health and well-being sector, and its social impact.


SalWe produces research-based data that creates a competitive advantage for companies in developing products, services and practices.


The focus is on maintaining and improving individual functioning. SalWe seeks to prevent, detect and treat diseases with serious social impact, such as brain dysfunction, injury and stress, lifestyle diseases, microbial infections and inflammation, and certain cancers.


The common feature of SalWe’s activities is individually tailored monitoring and management of health, well-being and lifestyles.


SalWe Ltd has 33 shareholders, 19 of them companies and 14 research organizations. It was established in 2009 and, in the same year, was officially designated a Strategic Centre for Science, Technology and Innovation in Health and Well-being.


Board of Directors

Tuula Romppanen, Orion Diagnostica (chair)
Carita Hirvonen, Tieto Healthcare & Welfare
Juha Hämäläinen, Elekta
Anu Jalanko, National Institute for Health and Welfare
Jarmo Laine, Nexstim
Maritta Perälä-Heape, University of Oulu
Mika Peteri, Mawell
Bill Östman, Thermo Fisher Scientific
Tuula Tuure, Valio
Hanna Viertiö-Oja, GE Healthcare Finland (deputy chair)
Saara Hassinen, SalWe Oy (secretary, SalWe managing director)









SalWe research sheds new light on brain dysfunction, lifestyle diseases and cancers. There are 33 SalWe shareholders, 19 of them companies and 14 research organizations.






SalWe Oy    Vaisalantie 6, 02130 Espoo   puh. +358 (0)50 304 5934